Work

The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies

Year: 2020

Type: review

Source: Nature Immunology

DOI: 10.1038/s41590-020-0728-z

Authors: Tobias Bald, Matthew F. Krummel, Mark J. Smyth, Kevin C. Barry

Institutions: QIMR Berghofer Medical Research Institute, University of California, San Francisco, Parker Institute for Cancer Immunotherapy, Fred Hutch Cancer Center

Language: English

Topic: Immune Cell Function and Interaction

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Health and Human Services, Cancer Research Institute, National Health and Medical Research Council, Cancer Council Queensland, National Cancer Institute

Awards: New methods to improve cancer immunotherapy, Immunotherapy in cancer and virus infection, Regulation of T cell Functions by the Breast Cancer Microenvironment, G3187337722, G5673059026, Targeting immune suppressive neutrophils to improve cancer immunotherapy, G7632256373, Integrating targeted and immunotherapy to treat genetically heterogeneous cancers, The Tumor Microenvironment Niche of Type I conventional Dendritic Cells

OpenAlex ID: W3043781639

FWCI: 5.761

Cites: 223

Cited by: 508

Related to: 10